Literature DB >> 8869445

A combination with clinical recommended dosages of salmeterol and ipratropium is not more effective than salmeterol alone in patients with chronic obstructive pulmonary disease.

M G Matera1, M Caputi, M Cazzola.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8869445     DOI: 10.1016/s0954-6111(96)90178-x

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


× No keyword cloud information.
  7 in total

Review 1.  Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.

Authors:  B Jarvis; A Markham
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 2.  Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease.

Authors:  S Appleton; T Jones; P Poole; L Pilotto; R Adams; T J Lasserson; B Smith; J Muhammad
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

3.  Acute effect of pretreatment with single conventional dose of salmeterol on dose-response curve to oxitropium bromide in chronic obstructive pulmonary disease.

Authors:  M Cazzola; F Di Perna; S Centanni; C Califano; C F Donner; M D'Amato; G D'Amato
Journal:  Thorax       Date:  1999-12       Impact factor: 9.139

Review 4.  Long-acting beta2 agonists in the management of stable chronic obstructive pulmonary disease.

Authors:  M Cazzola; C F Donner
Journal:  Drugs       Date:  2000-08       Impact factor: 9.546

Review 5.  Is combination therapy with inhaled anticholinergics and beta2-adrenoceptor agonists justified for chronic obstructive pulmonary disease?

Authors:  Chakravarthy B Reddy; Richard E Kanner
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 6.  Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease.

Authors:  S Appleton; T Jones; P Poole; L Pilotto; R Adams; T J Lasserson; B Smith; J Muhammad
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

Review 7.  Anti-cholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease.

Authors:  D C McCrory; C D Brown
Journal:  Cochrane Database Syst Rev       Date:  2002
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.